Successful bone marrow transplantation against mixed lymphocyte culture barrier.

Abstract:

:If bone marrow transplantation is to become widely applicable in the treatment of patients with leukemia and aplastic anemia, the necessity to have a perfectly histocompatible donor must be overcome. In an effort to define the roles of HL-A type and mixed lymphocyte culture (MLC) reactivity in the determination of successful engraftment and the occurrence of graftversus-host disease (GVHD), we have attempted transplantation of a child with acute myeloblastic leukemia (AML) using an HL-A identical, MLC-reactive sibling donor. Successful engraftment has been accomplished, as documented by the appearance of multiple donor genetic markers in the recipient. There is no evidence of severe GVHD. The recipient is alive, without evidence of leukemia, and has returned to full activities 9 mo after transplantation. The recipient now produces lymphocytes, which have the MLC reactivity that characterize the donor's lymphocytes, rather than that of her own pretransplant lymphocytes. This experience demonstrates that successful bone marrow transplantation in patients with leukemia can be accomplished in the face of MLC reactivity.

journal_name

Blood

journal_title

Blood

authors

Feig SA,Opelz G,Winter HS,Falk PM,Neerhout RC,Sparkes R,Gale RP

subject

Has Abstract

pub_date

1976-09-01 00:00:00

pages

385-91

issue

3

eissn

0006-4971

issn

1528-0020

journal_volume

48

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin.

    abstract::Thrombin Metz and normal thrombin, resulting from activation of the respective prothrombins by factor Xa in the presence of calcium, phospholipid, and factor Va, were purified by chromatography on sulfopropyl Sephadex. By physicochemical criteria, thrombin Metz is identical to normal thrombin. Its functional propertie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rabiet MJ,Jandrot-Perrus M,Boissel JP,Elion J,Josso F

    更新日期:1984-04-01 00:00:00

  • A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells.

    abstract::Adaptive immunity is triggered at the immune synapse, where peptide-major histocompatibility complexes and costimulatory molecules expressed by dendritic cells (DCs) are physically presented to T cells. Here we describe transmission of the inflammatory monoamine serotonin (5-hydroxytryptamine [5-HT]) between these cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2903

    authors: O'Connell PJ,Wang X,Leon-Ponte M,Griffiths C,Pingle SC,Ahern GP

    更新日期:2006-02-01 00:00:00

  • Thalidomide as salvage therapy for chronic graft-versus-host disease.

    abstract::Thalidomide has been reported to be an effective agent for treatment of chronic graft-versus-host disease (CGVHD). To determine the efficacy of this agent in patients with refractory CGVHD a total of 80 patients who failed to respond to prednisone (PSE) or PSE and cyclosporine (CSA) were treated with thalidomide. Sixt...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Parker PM,Chao N,Nademanee A,O'Donnell MR,Schmidt GM,Snyder DS,Stein AS,Smith EP,Molina A,Stepan DE,Kashyap A,Planas I,Spielberger R,Somlo G,Margolin K,Zwingenberger K,Wilsman K,Negrin RS,Long GD,Niland JC,Blume K

    更新日期:1995-11-01 00:00:00

  • Human erythropoietin gene therapy for patients with chronic renal failure.

    abstract::Gene therapy holds a major promise. However, until now, this promise was fulfilled only in few cases, in rare genetic diseases. One very common clinical condition is anemia. Patients with anemia of chronic renal failure are treated with erythropoietin. The objective of this study was to develop a therapeutic platform ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4174

    authors: Lippin Y,Dranitzki-Elhalel M,Brill-Almon E,Mei-Zahav C,Mizrachi S,Liberman Y,Iaina A,Kaplan E,Podjarny E,Zeira E,Harati M,Casadevall N,Shani N,Galun E

    更新日期:2005-10-01 00:00:00

  • Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.

    abstract::Seventy-one patients with hematologic malignancies received bone marrow from a histocompatible sibling (n = 48) or a partially matched relative (n = 23) that had been depleted of CD5+ T cells with either an anti-CD5 mooclonal antibody (MoAb) plus complement (anti-Leu1 + C) or an anti-CD5 MoAb conjugated to ricin A cha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Antin JH,Bierer BE,Smith BR,Ferrara J,Guinan EC,Sieff C,Golan DE,Macklis RM,Tarbell NJ,Lynch E

    更新日期:1991-10-15 00:00:00

  • Toward optimizing pomalidomide therapy in MM patients.

    abstract::In this issue of Blood, Sehgal et al report on the clinical and pharmacodynamics analysis of pomalidomide dosing strategies in multiple myeloma (MM) and their impact on immune activation and cereblon targets. The particular novelty of this study lies in the direct correlation of immune effects triggered by pomalidomid...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-05-641746

    authors: Podar K

    更新日期:2015-06-25 00:00:00

  • Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging.

    abstract::DNA methylation plays an important role in the self-renewal of hematopoietic stem cells and in the commitment to the lymphoid or myeloid lineages. Using purified CD34⁺ hematopoietic progenitor cells and differentiated myeloid cell populations from the same human samples, we obtained detailed methylation profiles at di...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-331926

    authors: Bocker MT,Hellwig I,Breiling A,Eckstein V,Ho AD,Lyko F

    更新日期:2011-05-12 00:00:00

  • p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia.

    abstract::We studied the expression of the two tumor necrosis factor (TNF) receptors, p55 and p75, on B cells from patients with chronic lymphocytic leukemia (CLL), and the presence of soluble TNF receptors in serum. Expression of membrane-associated receptors was quantified by double labeling of peripheral blood mononuclear ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Waage A,Liabakk N,Lien E,Lamvik J,Espevik T

    更新日期:1992-11-15 00:00:00

  • Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways.

    abstract::When overexpressed in primary erythroid progenitors, oncogenic Ras leads to the constitutive activation of its downstream signaling pathways, severe block of terminal erythroid differentiation, and cytokine-independent growth of primary erythroid progenitors. However, whether high-level expression of oncogenic Ras is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-047050

    authors: Zhang J,Liu Y,Beard C,Tuveson DA,Jaenisch R,Jacks TE,Lodish HF

    更新日期:2007-06-15 00:00:00

  • Impaired germinal center formation and recall T-cell-dependent immune responses in mice lacking the costimulatory ligand B7-H2.

    abstract::B7-H2, which is expressed constitutively on B cells and binds the inducible costimulator (ICOS) on antigen-activated T cells, is a member of the B7 family of costimulatory ligands. We have inactivated B7-H2 in the mouse. B7-H2-/- mice generate normal populations of B and T cells in their various lymphoid organs but ha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-08-2416

    authors: Wong SC,Oh E,Ng CH,Lam KP

    更新日期:2003-08-15 00:00:00

  • Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9

    abstract::Cloned T9-C2 glioma cells transfected with membrane macrophage colony-stimulating factor (mM-CSF) never formed subcutaneous tumors when implanted into Fischer rats, whereas control T9 cells did. The T9-C2 cells were completely killed within 1 day through a mechanism that resembled paraptosis. Vacuolization of the T9-C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0174

    authors: Chen Y,Douglass T,Jeffes EW,Xu Q,Williams CC,Arpajirakul N,Delgado C,Kleinman M,Sanchez R,Dan Q,Kim RC,Wepsic HT,Jadus MR

    更新日期:2002-08-15 00:00:00

  • Maea expressed by macrophages, but not erythroblasts, maintains postnatal murine bone marrow erythroblastic islands.

    abstract::The erythroblastic island (EI), formed by a central macrophage and developing erythroblasts (EBs), was first described decades ago and was recently shown to play an in vivo role in homeostatic and pathological erythropoiesis. The exact molecular mechanisms, however, mediating the interactions between macrophages and E...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-11-888180

    authors: Wei Q,Boulais PE,Zhang D,Pinho S,Tanaka M,Frenette PS

    更新日期:2019-03-14 00:00:00

  • A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.

    abstract::Host defenses in the human neonate are limited by immaturity in phagocytic immunity. Such limitations seem to predispose infected newborns to neutropenia from an exhaustion of the neutrophil reserve. Among the critical defects thus far identified in neonatal phagocytic immunity is a specific reduction in the capacity ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Gillan ER,Christensen RD,Suen Y,Ellis R,van de Ven C,Cairo MS

    更新日期:1994-09-01 00:00:00

  • Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production.

    abstract::A defect in erythropoietin (EPO) production has been advocated as being the main cause of anemia presented at time of diagnosis or during treatment by adults with solid tumors. On the basis of this defect, anemic cancer patients, both adults and children, have been treated with recombinant human EPO (rHuEPO). To furth...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Corazza F,Beguin Y,Bergmann P,André M,Ferster A,Devalck C,Fondu P,Buyse M,Sariban E

    更新日期:1998-09-01 00:00:00

  • Gene therapy. Factor IX Padua: them that have, give.

    abstract::In this issue of Blood, Finn et al have taken a factor IX variant with increased specific activity associated with thrombophilia and used it to improve gene therapy of hemophilia B in dogs, and Cantore et al have shown similar results in mice. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-09-452821

    authors: Lozier JN

    更新日期:2012-11-29 00:00:00

  • 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins.

    abstract::Cyclopentenone prostaglandins are potent inhibitors of nuclear factor-kappa B (NF-kappa B), a transcription factor with a critical role in promoting inflammation and connected with multiple aspects of oncogenesis and cancer cell survival. In the present report, we investigated the role of NF-kappa B in the antineoplas...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-04-1360

    authors: Piva R,Gianferretti P,Ciucci A,Taulli R,Belardo G,Santoro MG

    更新日期:2005-02-15 00:00:00

  • Delivery of progenitors to the thymus limits T-lineage reconstitution after bone marrow transplantation.

    abstract::T-cell production depends on the recruitment of hematopoietic progenitors into the thymus. T cells are among the last of the hematopoietic lineages to recover after bone marrow transplantation (BMT), but the reasons for this delay are not well understood. Under normal physiologic conditions, thymic settling is selecti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-324954

    authors: Zlotoff DA,Zhang SL,De Obaldia ME,Hess PR,Todd SP,Logan TD,Bhandoola A

    更新日期:2011-08-18 00:00:00

  • Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia.

    abstract::High doses of recombinant factor VIIa are useful in managing bleeding in hemophiliacs with inhibitors. Whether this therapeutic effect of factor VIIa is dependent on tissue factor (TF) is a matter of debate. We examined the ability of freshly isolated human monocytes (which lack TF) to support the activation of coagul...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hoffman M,Monroe DM,Roberts HR

    更新日期:1994-01-01 00:00:00

  • Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura.

    abstract::Extracorporeal immunoadsorption of plasma to remove IgG and circulating immune complexes (CIC) was evaluated as a therapy for adults with treatment-resistant immune thrombocytopenic purpura (ITP). Seventy-two patients with initial platelet counts less than 50,000/microL who had failed at least two other therapies were...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Snyder HW Jr,Cochran SK,Balint JP Jr,Bertram JH,Mittelman A,Guthrie TH Jr,Jones FR

    更新日期:1992-05-01 00:00:00

  • Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?

    abstract::Notch signaling pathway regulates many different events of embryonic and adult development; among them, Notch plays an essential role in the onset of hematopoietic stem cells and influences multiple maturation steps of developing lymphoid and myeloid cells. Deregulation of Notch signaling determines several human diso...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-08-376061

    authors: Nwabo Kamdje AH,Krampera M

    更新日期:2011-12-15 00:00:00

  • Prognostic significance of thrombocytosis in idiopathic sideroblastic anemia.

    abstract::In order to determine the prognostic significance of thrombocytosis in idiopathic sideroblastic anemia, the clinical courses of 17 patients were reviewed. Six patients (36%) had thrombocytosis, and none developed acute leukemia. Nine patients (53%) had normal platelet counts, and one developed acute leukemia. Two pati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Streeter RR,Presant CA,Reinhard E

    更新日期:1977-09-01 00:00:00

  • Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment.

    abstract::In ischemic stroke, treatment options are limited. Therapeutic thrombolysis is restricted to the first few hours after stroke, and the utility of current platelet aggregation inhibitors, including GPIIb/IIIa receptor antagonists, and anticoagulants is counterbalanced by the risk of intracerebral bleeding complications...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2008-04-144758

    authors: Stoll G,Kleinschnitz C,Nieswandt B

    更新日期:2008-11-01 00:00:00

  • Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice.

    abstract::BRCA1 is critical for maintenance of genomic stability and interacts directly with several proteins that regulate hematopoietic stem cell function and are part of the Fanconi anemia (FA) double-strand break DNA repair pathway. The effects of complete BRCA1 deficiency on bone marrow (BM) function are unknown. To test t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-03-635599

    authors: Vasanthakumar A,Arnovitz S,Marquez R,Lepore J,Rafidi G,Asom A,Weatherly M,Davis EM,Neistadt B,Duszynski R,Vardiman JW,Le Beau MM,Godley LA,Churpek JE

    更新日期:2016-01-21 00:00:00

  • Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibition.

    abstract::Several signaling cascades are engaged by expression of the p210 bcr-abl tyrosine kinase, and evidence suggests that these signals drive leukemogenesis. In this report, signaling pathways were examined and compared between cells derived from leukemic patients and cells expressing a bcr-abl construct (MBA). The effects...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.9.2846

    authors: Donato NJ,Wu JY,Zhang L,Kantarjian H,Talpaz M

    更新日期:2001-05-01 00:00:00

  • Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.

    abstract::Aberrant activation of the Wnt pathway plays a pathogenetic role in various tumors and has been associated with adverse outcome in acute lymphoblastic leukemia (ALL). LEF1, a key mediator of Wnt signaling, has been linked to leukemic transformation, and recurrent mutations of LEF1 have been identified in pediatric T-A...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2011-04-350850

    authors: Kühnl A,Gökbuget N,Kaiser M,Schlee C,Stroux A,Burmeister T,Mochmann LH,Hoelzer D,Hofmann WK,Thiel E,Baldus CD

    更新日期:2011-12-08 00:00:00

  • GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.

    abstract::We designed a trial in which postremission therapy of young patients with de novo acute myeloid leukemia (AML) was decided combining cytogenetics/genetics and postconsolidation levels of minimal residual disease (MRD). After induction and consolidation, favorable-risk patients (FR) were to receive autologous stem cell...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood.2018886960

    authors: Venditti A,Piciocchi A,Candoni A,Melillo L,Calafiore V,Cairoli R,de Fabritiis P,Storti G,Salutari P,Lanza F,Martinelli G,Luppi M,Mazza P,Martelli MP,Cuneo A,Albano F,Fabbiano F,Tafuri A,Chierichini A,Tieghi A,Frac

    更新日期:2019-09-19 00:00:00

  • Hepatosplenic candidiasis--a contraindication to marrow transplantation?

    abstract::To determine whether a prior history of hepatosplenic candidiasis resulted in increased Candida-associated morbidity and mortality after marrow transplant, 15 consecutive patients with biopsy-proven hepatosplenic candidiasis were observed prospectively. All patients received amphotericin B before transplant. Amphoteri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bjerke JW,Meyers JD,Bowden RA

    更新日期:1994-10-15 00:00:00

  • Transfusion-associated AIDS: donor-recipient human immunodeficiency virus exhibits genetic heterogeneity.

    abstract::The genetic diversity of the human immunodeficiency virus (HIV) isolated from transfusion-associated AIDS patients has been examined. Restriction enzyme mapping studies of integrated proviral DNA of donor and recipient origin demonstrated genomic variation between isolates. Analysis of the molecularly cloned viral gen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Srinivasan A,York D,Ranganathan P,Ferguson R,Butler D Jr,Feorino P,Kalyanaraman V,Jaffe H,Curran J,Anand R

    更新日期:1987-06-01 00:00:00

  • A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation.

    abstract::A1, a bcl-2 family member, has been identified as a hematopoietic-specific, early inducible gene. In this study it is shown that stable transfection of A1 into an interleukin-3 (IL-3)-dependent myeloid precursor cell line, 32D c13, leads to a retardation of IL-3 withdrawal-induced cell death similar to that observed w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lin EY,Orlofsky A,Wang HG,Reed JC,Prystowsky MB

    更新日期:1996-02-01 00:00:00

  • The T-cell CD2 determinant mediates inhibition of erythropoiesis by the lymphokine cascade.

    abstract::We examined the role of the T-cell antigen CD2 in the regulation of erythropoiesis by the lymphokine cascade. T-cell interleukin-2 (IL-2) receptors (p55) were induced via triggering of the antigen receptor-associated CD3 epitope. Before CD3 triggering T cells were preincubated with a CD2-blocking (Leu-5b) or isotype c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Burdach S,Shatsky M,Wagenhorst B,Levitt L

    更新日期:1988-08-01 00:00:00